Pinnacle Wealth Planning Services, Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Pinnacle Wealth Planning Services, Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$334,291
+13.7%
21,609
+15.4%
0.06%
+17.0%
Q2 2023$294,092
-9.2%
18,720
-4.7%
0.05%
-13.0%
Q1 2023$323,881
-10.8%
19,653
-15.6%
0.05%
-16.9%
Q4 2022$363,137
+40.2%
23,278
+16.6%
0.06%
+35.4%
Q3 2022$259,000
-37.7%
19,962
-32.7%
0.05%
-36.0%
Q2 2022$416,000
+21.3%
29,654
+23.9%
0.08%
+21.0%
Q1 2022$343,000
-22.9%
23,928
-26.8%
0.06%
-28.7%
Q4 2021$445,000
-4.9%
32,688
+14.5%
0.09%
-15.5%
Q3 2021$468,000
-0.2%
28,542
+2.3%
0.10%
-5.5%
Q2 2021$469,000
-0.6%
27,891
+7.8%
0.11%
-9.9%
Q1 2021$472,000
+11.1%
25,866
+10.9%
0.12%
+18.6%
Q4 2020$425,000
+34.1%
23,331
+31.3%
0.10%
-2.9%
Q3 2020$317,000
+2.3%
17,768
+2.5%
0.10%
+4.0%
Q2 2020$310,000
-10.9%
17,329
-24.6%
0.10%
-38.8%
Q1 2020$348,000
-26.3%
22,987
-4.0%
0.16%
-25.7%
Q4 2019$472,000
+20.4%
23,954
+4.9%
0.22%
+4.2%
Q3 2019$392,000
+9.2%
22,842
+12.6%
0.21%
-1.8%
Q2 2019$359,000
-5.8%
20,278
+8.5%
0.22%
-15.2%
Q1 2019$381,000
-42.8%
18,685
-40.1%
0.26%
-58.0%
Q3 2018$666,000
+9.0%
31,176
+6.7%
0.61%
+2.7%
Q2 2018$611,000
+3.0%
29,217
+20.2%
0.59%
-2.8%
Q1 2018$593,00024,3010.61%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2020
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders